IHC staining of the patient tumors corresponding to the PDEC revealed that the HER2‐positive tumors were also positive for SorLA expression, while HER2‐negative tumor expressed low SorLA levels (Fig. S5). The gene discussed is ERBB2; the disease is neoplasm.